8-K/A: Forian Inc. Acquires Kyber Data Science LLC, Files Amended 8-K with Pro Forma Financials

Forian Inc. has amended its initial 8-K filing to include the financial statements of Kyber Data Science LLC, following its acquisition on October 31, 2024.

Summary

• Forian Inc. acquired Kyber Data Science LLC on October 31, 2024, and this amended 8-K filing includes Kyber's audited financials for the year ended December 31, 2023, and unaudited financials for the nine months ended September 30, 2024.
• The filing also presents unaudited pro forma combined financial statements for Forian and Kyber, as if the acquisition had occurred on September 30, 2024, for the balance sheet, and at the beginning of 2023 for the statements of operations.
• Kyber's audited financials for 2023 show a net loss of $12.32 million on revenues of $4.16 million, while the unaudited financials for the nine months ended September 30, 2024, show a net loss of $8.21 million on revenues of $3.43 million.
• The pro forma combined financials are for informational purposes only and do not represent future performance or financial position.
• The acquisition was completed with Forian assuming Kyber's liabilities and no cash consideration was paid to the sellers.

Sentiment

Score: 4

Explanation: The document highlights a strategic acquisition but also reveals significant losses at Kyber, leading to a mixed sentiment. The lack of cash consideration is a positive, but the losses are a concern.

Positives

• The acquisition of Kyber Data Science LLC expands Forian's capabilities in healthcare data analytics.
• The pro forma financials provide a view of the combined entity's potential financial position and results of operations.
• The acquisition was completed without any cash consideration, with Forian assuming Kyber's liabilities.

Negatives

• Kyber Data Science LLC has been operating at a loss, with a net loss of $12.32 million in 2023 and $8.21 million for the first nine months of 2024.
• The pro forma combined financials also show significant net losses for both the nine months ended September 30, 2024, and the year ended December 31, 2023.
• The unaudited pro forma financials are not indicative of future performance.

Risks

• The pro forma financial statements are based on estimates and may differ materially from actual results.
• The integration of Kyber's operations into Forian may present challenges.
• Kyber's historical losses may continue to impact the combined entity's profitability.
• The company has not completed a formal valuation of Kyber's assets and liabilities, which could lead to material changes in the pro forma financials.

Future Outlook

The unaudited pro forma condensed combined financial statements are for informational purposes only and are not intended to represent or be indicative of the future financial position or results of operations of the company.

Industry Context

The acquisition of Kyber Data Science LLC aligns with the trend of consolidation in the healthcare data analytics industry, as companies seek to expand their capabilities and market reach.

Comparison to Industry Standards

• Kyber's financial performance, with significant losses, is not uncommon for early-stage data analytics companies, which often require substantial investment in technology and data acquisition.
• Compared to established players in the healthcare data analytics space, such as IQVIA or Optum, Kyber is a smaller entity with a more focused product offering.
• The pro forma combined financials will need to be monitored closely to assess the impact of the acquisition on Forian's overall financial performance.

Related Party Transactions

• Kyber has significant payable to affiliates, primarily to Cowen Services Company, LLC, for support services.
• Amounts due to the Parent were converted to equity contributions on January 31, 2024 and September 30, 2024.

Stakeholder Impact

• Shareholders of Forian will be impacted by the acquisition and the combined entity's financial performance.
• Employees of Kyber will become part of Forian.
• Customers of Kyber will continue to receive services from Forian.
• Suppliers and creditors of Kyber will now be dealing with Forian.

Next Steps

• Forian will integrate Kyber's operations and technology into its existing business.
• The company will finalize the valuation of Kyber's assets and liabilities.
• Forian will monitor the performance of the combined entity and report on its progress in future filings.

Key Dates

Keywords

acquisition, financial statements, pro forma, healthcare data, Kyber Data Science, Forian Inc, data analytics, merger